Skin cancer drug Tafinlar now available for NHS patients

Novartis has announced the first BRAF-targeted treatment for post-surgery stage III melanoma patients, the most aggressive type of skin cancer, is to be made...

Follow us

Cancer Research UK launches London biotherapeutics hub

The city of London will be transformed into a world leading hub for cancer biotherapeutics research and treatment, with a new £14 million investment...

New standards launched to improve public involvement in research

New national standards to improve the quality of public involvement in research.

Have analytics been relegated to a reporting function?

Have business analytics been pushed to the background? Business information upgraded, smart CRM datasets, the Predictive Analytics silver bullet and other fairy tales.

Is Brexit good news for pharma?

James Burt, Executive Vice President EMENA, Accord Healthcare, asks whether Brexit will in fact present an opportunity for positive change in pharma and healthcare.

What do NHS changes mean for tech innovation?

Could changes at the top mean fresh opportunities for tech innovation? Read this in the August issue of Pf Magazine.  For some time it has been...

Certara appoint Dr Mark Holbrook as VP of QSTS division

Certara ®, a leader in model-informed drug development, regulatory science, market access and real-world evidence services, has announced that it has appointed Mark Holbrook,...

Jobs of the week

Brands by numbers: Launch excellence in an increasingly specialised world

As the focus turns to specialist therapy areas and competition increases, achieving a successful launch is becoming even more challenging.

Implementing the national brand strategy at local level

National brand messages for general biological medicines must be tailored to patients and clinicians at a local level, and dovetailed with the needs, priorities...

How to harness the power of data for brand planning

Brand planning: Getting general biological brands established in a fast changing and cash-strapped NHS requires deep customer insight and a strong evidence-based strategy that will...